Risk of Pediatric Celiac Disease According to HLA Haplotype and Country

被引:229
作者
Liu, Edwin [1 ,2 ]
Lee, Hye-Seung [3 ]
Aronsson, Carin A. [4 ]
Hagopian, William A. [5 ]
Koletzko, Sibylle [6 ]
Rewers, Marian J. [2 ]
Eisenbarth, George S. [2 ]
Bingley, Polly J. [9 ]
Bonifacio, Ezio [7 ,8 ]
Simell, Ville [10 ]
Agardh, Daniel [4 ]
机构
[1] Univ Colorado Denver, Digest Hlth Inst, Childrens Hosp Colorado, Aurora, CO USA
[2] Univ Colorado Denver, Barbara Davis Ctr, Aurora, CO USA
[3] Univ S Florida, Pediat Epidemiol Ctr, Tampa, FL USA
[4] Lund Univ, Diabet & Celiac Dis Unit, Dept Clin Sci, Malmo, Sweden
[5] Pacific Northwest Diabet Res Inst, Seattle, WA USA
[6] Univ Munich, Dr Von Haunerschen Kinderspital, D-80337 Munich, Germany
[7] Tech Univ Dresden, Ctr Regenerat Therapies Dresden, D-01062 Dresden, Germany
[8] Helmholz Zentrum Munchen, Forschergrp Diabet, Neuherberg, Germany
[9] Univ Bristol, Sch Clin Sci, Bristol, Avon, England
[10] Univ Turku, Dept Pediat, Turku Univ Hosp, Turku, Finland
关键词
GENE DOSAGE; AUTOIMMUNITY; ANTIBODIES; CHILDHOOD; CHILDREN; GLUTEN;
D O I
10.1056/NEJMoa1313977
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The presence of HLA haplotype DR3-DQ2 or DR4-DQ8 is associated with an increased risk of celiac disease. In addition, nearly all children with celiac disease have serum antibodies against tissue transglutaminase (tTG). Methods We studied 6403 children with HLA haplotype DR3-DQ2 or DR4-DQ8 prospectively from birth in the United States, Finland, Germany, and Sweden. The primary end point was the development of celiac disease autoimmunity, which was defined as the presence of tTG antibodies on two consecutive tests at least 3 months apart. The secondary end point was the development of celiac disease, which was defined for the purpose of this study as either a diagnosis on biopsy or persistently high levels of tTG antibodies. Results The median follow-up was 60 months (interquartile range, 46 to 77). Celiac disease autoimmunity developed in 786 children (12%). Of the 350 children who underwent biopsy, 291 had confirmed celiac disease; an additional 21 children who did not undergo biopsy had persistently high levels of tTG antibodies. The risks of celiac disease autoimmunity and celiac disease by the age of 5 years were 11% and 3%, respectively, among children with a single DR3-DQ2 haplotype, and 26% and 11%, respectively, among those with two copies (DR3-DQ2 homozygosity). In the adjusted model, the hazard ratios for celiac disease autoimmunity were 2.09 (95% confidence interval [CI], 1.70 to 2.56) among heterozygotes and 5.70 (95% CI, 4.66 to 6.97) among homozygotes, as compared with children who had the lowest-risk genotypes (DR4-DQ8 heterozygotes or homozygotes). Residence in Sweden was also independently associated with an increased risk of celiac disease autoimmunity (hazard ratio, 1.90; 95% CI, 1.61 to 2.25). Conclusions Children with the HLA haplotype DR3-DQ2, especially homozygotes, were found to be at high risk for celiac disease autoimmunity and celiac disease early in childhood. The higher risk in Sweden than in other countries highlights the importance of studying environmental factors associated with celiac disease. (Funded by the National Institute of Diabetes and Digestive and Kidney Diseases and others.)
引用
收藏
页码:42 / 49
页数:8
相关论文
共 21 条
[1]  
Andren Aronsson C, 2013, MATERN CHILD NUTR
[2]   Comparison of tissue transglutaminase-specific antibody assays with established antibody measurements for coeliac disease [J].
Bazzigaluppi, E ;
Lampasona, V ;
Barera, G ;
Venerando, A ;
Bianchi, C ;
Chiumello, G ;
Bonifacio, E ;
Bosi, E .
JOURNAL OF AUTOIMMUNITY, 1999, 12 (01) :51-56
[3]   The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants [J].
Hagopian, William A. ;
Erlich, Henry ;
Lernmark, Ake ;
Rewers, Marian ;
Ziegler, Anette G. ;
Simell, Olli ;
Akolkar, Beena ;
Vogt, Robert, Jr. ;
Blair, Alan ;
Ilonen, Jorma ;
Krischer, Jeffrey ;
She, JinXiong .
PEDIATRIC DIABETES, 2011, 12 (08) :733-743
[4]   Transglutaminase antibodies in children with a genetic risk for celiac disease [J].
Hoffenberg, EJ ;
Bao, F ;
Eisenbarth, GS ;
Uhlhorn, C ;
Haas, JE ;
Sokol, RJ ;
Rewers, M .
JOURNAL OF PEDIATRICS, 2000, 137 (03) :356-360
[5]   A prospective study of the incidence of childhood celiac disease [J].
Hoffenberg, EJ ;
MacKenzie, T ;
Barriga, KJ ;
Eisenbarth, GS ;
Bao, F ;
Haas, JE ;
Erlich, H ;
Bugawan, TL ;
Sokol, RJ ;
Taki, I ;
Norris, JM ;
Rewers, M .
JOURNAL OF PEDIATRICS, 2003, 143 (03) :308-314
[6]   Development of celiac disease-associated antibodies in offspring of parents with Type I diabetes [J].
Hummel, M ;
Bonifacio, E ;
Stern, M ;
Dittler, J ;
Schimmel, A ;
Ziegler, AG .
DIABETOLOGIA, 2000, 43 (08) :1005-1011
[7]   European Society for Pediatric Gastroenterology, Hepatology, and Nutrition Guidelines for the Diagnosis of Coeliac Disease [J].
Husby, S. ;
Koletzko, S. ;
Korponay-Szabo, I. R. ;
Mearin, M. L. ;
Phillips, A. ;
Shamir, R. ;
Troncone, R. ;
Giersiepen, K. ;
Branski, D. ;
Catassi, C. ;
Lelgeman, M. ;
Maki, M. ;
Ribes-Koninckx, C. ;
Ventura, A. ;
Zimmer, K. P. .
JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2012, 54 (01) :136-160
[8]   Epidemic of coeliac disease in Swedish children [J].
Ivarsson, A ;
Persson, LÅ ;
Nyström, I ;
Ascher, H ;
Cavell, B ;
Danielsson, L ;
Dannaeus, A ;
Lindberg, T ;
Lindquist, B ;
Stenhammar, L ;
Hernell, O .
ACTA PAEDIATRICA, 2000, 89 (02) :165-171
[9]  
Krischer J, 2007, PEDIATR DIABETES, V8, P286
[10]   Enrollment experiences in a pediatric longitudinal observational study: The Environmental Determinants of Diabetes in the Young (TEDDY) study [J].
Lernmark, Barbro ;
Johnson, Suzanne Bennett ;
Vehik, Kendra ;
Smith, Laura ;
Ballard, Lori ;
Baxter, Judy ;
McLeod, Wendy ;
Roth, Roswith ;
Simell, Tuula .
CONTEMPORARY CLINICAL TRIALS, 2011, 32 (04) :517-523